Market Research Reports https://www.marketsandmarkets.com/MarketsandMarkets XML Feed en-us Copyright MarketsandMarkets 4/26/2024 9:29:49 AM GMT 4/26/2024 9:29:49 AM GMT 300 Market Research Reports https://www.marketsandmarkets.com/ MarketsandMarkets – Market Research Company publishes about 120 business market researchreports a year across 10 main industries. Market research reports and industry trends analysis available from MarketsandMarkets.4/26/2024 9:29:49 AM GMT Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.htmlThe global pen needles market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 9.1% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....10/16/2023 GMT Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centres) & Region - Global Forecast to 2027..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/needles-market-223979930.htmlThe needles market is projected to reach USD 10.6 billion by 2027, at a CAGR of 6.7% during the forecast period. The major players in the Needles Market are Becton, Dickinson, and Company (US), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), and Stryker Corporation (US)....11/9/2022 GMT Pharmaceutical Drug Delivery Market Size by Route of Administration (Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes), Application (Cancer, Diabetes), Facility of Use (Hospitals) & Region - Global Forecast to 2026..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.htmlThe size of global pharmaceutical drug delivery market in terms of revenue was estimated to be worth USD 1,656.9 billion in 2021 and is poised to reach USD 2,206.5 billion by 2026, growing at a CAGR of 5.9% from 2021 to 2026. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....11/15/2021 GMT Prefilled Syringes Market Size by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) & Region - Global Forecast to 2025..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/prefilled-syringes-market-16618331.htmlThe size of global prefilled syringes market in terms of revenue was estimated to be worth USD 5.6 billion in 2020 and is poised to reach USD 8.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. ...9/17/2020 GMT Syringes Market Size by Type (General & Specialized Syringes (insulin, tuberculin)), Usability (Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safety, prefilled)), Material (Glass & Plastic Syringes)..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/syringes-market-34590618.htmlThe global syringes market size is projected to grow at a CAGR of 8.7%. High prevalence of chronic diseases across the globe, rising geriatric population, increasing adoption of safety syringes, technological advancements, and increasing demand for vaccines are supporting the market growth of syringes. However, high cost of safety syringes and increasing incidence of needle stick injuries are the major challenges in global Market....11/11/2016 GMT North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/north-american-drug-delivery-technologies-market-1209.htmlThe North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is primarily driven by the rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements. However, risk of needlestick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years....8/29/2016 GMT European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.htmlThe European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market....7/28/2015 GMT European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/european-drug-delivery-technologies-market-1194.htmlThe Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. ...6/19/2013 GMT North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/north-america-injectable-drug-delivery-market-1109.htmlThe North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices....4/4/2013 GMT Drug Device Combination – (2009 - 2014)..., Market Research Report: MarketsandMarketshttps://www.marketsandmarkets.com/Market-Reports/drug-and-device-combination-101.htmlThis report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications. ...11/17/2009 GMT